Cowen And Company, LLC Exagen Inc. Transaction History
Cowen And Company, LLC
- $3.88 Billion
- Q3 2024
A detailed history of Cowen And Company, LLC transactions in Exagen Inc. stock. As of the latest transaction made, Cowen And Company, LLC holds 891,366 shares of XGN stock, worth $4.47 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
891,366
Previous 891,366
-0.0%
Holding current value
$4.47 Million
Previous $1.62 Million
69.79%
% of portfolio
0.07%
Previous 0.04%
Shares
14 transactions
Others Institutions Holding XGN
# of Institutions
38Shares Held
6.41MCall Options Held
4.5KPut Options Held
400-
Rtw Investments, LP New York, NY1.51MShares$7.59 Million0.07% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY541KShares$2.72 Million0.01% of portfolio
-
Stonepine Capital Management, LLC Bend, OR534KShares$2.68 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$2.46 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT490KShares$2.46 Million0.01% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $81.6M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...